Defining Intravenous Recombinant Tissue Plasminogen Activator Failure

被引:7
|
作者
Guerrero, Waldo R. [1 ]
Grotta, James C. [1 ]
机构
[1] Univ Texas Houston, Houston Med Sch, Houston, TX USA
基金
美国国家卫生研究院;
关键词
endovascular treatment; imaging; magnetic resonance imaging; reperfusion; TPA; thrombolysis; transcranial Doppler; ACUTE ISCHEMIC-STROKE; NO EARLY RECANALIZATION; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; INTRAARTERIAL; THROMBOLYSIS; THERAPY; IMPROVEMENT; REVASCULARIZATION; NEPHROPATHY;
D O I
10.1161/STROKEAHA.112.678888
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:819 / 821
页数:3
相关论文
共 50 条
  • [41] Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion
    Chen, Celia S.
    Lee, Andrew W.
    Campbell, Bruce
    Paine, Mark
    Lee, Tien
    Fraser, Clare
    Grigg, John
    Markus, Romesh
    Williams, Keryn
    Coster, Doug J.
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (01) : 87 - 89
  • [42] INTRAVENOUS ADMINISTRATION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR - OPTIMIZING THE RATE OF CORONARY THROMBOLYSIS
    PREWITT, RM
    GU, SA
    SCHICK, U
    DUCAS, J
    CHEST, 1995, 107 (04) : 1146 - 1151
  • [43] Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
    Hirano, Teruyuki
    NEUROLOGIA MEDICO-CHIRURGICA, 2015, 55 (10) : 789 - 795
  • [44] Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator
    Ong, Cheung-Ter
    Wong, Yi-Sin
    Wu, Chi-Shun
    Su, Yu-Hsiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1559 - 1566
  • [45] Expanding Recombinant Tissue Plasminogen Activator Time Window Is Premature
    Alper, Brian S.
    Brown, Cynthia B.
    STROKE, 2009, 40 (11) : E632 - E632
  • [46] Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism
    Yeguiayan, Jean Michel
    Benatru, Isabelle
    Guiu, Boris
    Abou Taam, Jamal
    Albertini, Serge
    Freysz, Marc
    Giroud, Maurice
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2011, 29 (08) : 961.e1 - 961.e4
  • [47] Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis
    Maiser, Samuel J.
    Georgiadis, Alexandros L.
    Suri, M. Fareed K.
    Vazquez, Gabriela
    Lakshminarayan, Kamakshi
    Qureshi, Adnan I.
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (01) : 25 - 32
  • [48] Efficacy and Safety of a Modified Intravenous Recombinant Tissue Plasminogen Activator Regimen in Chinese Patients with Acute Ischemic Stroke
    Pan, Shu-Ming
    Liu, Jia-Fu
    Liu, Ming
    Shen, Sa
    Li, Hao-Jun
    Dai, Li-Hua
    Chen, Xiang-Jun
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (05) : 690 - 693
  • [49] Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator
    Tanaka, Koji
    Matsumoto, Shoji
    Furuta, Konosuke
    Yamada, Takeshi
    Nagano, Sukehisa
    Takase, Kei-ichiro
    Hatano, Taketo
    Yamasaki, Ryo
    Kira, Jun-ichi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (04) : 545 - 550
  • [50] Recanalization of Middle Cerebral Artery and Intracranial Aneurysm in the Same Ischemic Territory With Intravenous Administration of Recombinant Tissue Plasminogen Activator: Case Report
    Matsuzaki, Toshinori
    Yoshino, Atsuo
    Sakatani, Kaoru
    Katayama, Yoichi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2011, 20 (03) : 269 - 272